Results 141 to 150 of about 8,771 (219)

Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 867-875, May 2026.
Achieving rapid control of itch in atopic dermatitis and prurigo nodularis may minimize symptomatology and disease burden. Analysis of clinical trials in atopic dermatitis and prurigo nodularis showed significantly more patients in nemolizumab versus placebo groups achieved a meaningful clinical response in itch within 48 h, and separation increased ...
Sonja Ständer, Sarina B. Elmariah, Shawn G. Kwatra, Gil Yosipovitch, Andrew E. Pink, Soo Yeon Cheong, Xiaoxiao Chen, Zarif K. Jabbar‐Lopez, Liliana Ulianov, Christophe Piketty, Jonathan I. Silverberg   +10 more
wiley   +1 more source

Efficacy of Upadacitinib in a Middle‐Aged Man With Netherton Syndrome Refractory to Dupilumab: A Case Report

The Journal of Dermatology, Volume 53, Issue 5, Page e359-e361, May 2026.
Bo‐Jie Yu, Pei‐Ling Li, Bing‐Sian Lin, Shou‐En Wu, Chih‐Tsung Hung   +4 more
wiley   +1 more source

Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure. [PDF]

J Clin Gastroenterol
Lee SD, Kamp KJ, Jacobs J, Harper J, Barahimi M, Clark-Snustad KD.   +5 more
europepmc   +1 more source

Successful Treatment of Crohn Disease and Concomitant Alopecia Totalis with Upadacitinib: Case Report and Systematic Review of the Literature. [PDF]

Acta Derm Venereol
Andersen YMF, Seyed-Alinaghi F, Kristiansen MF, Thomsen SF.   +3 more
europepmc   +1 more source

A Case of Pityriasis Lichenoides Chronica Successfully Treated With Upadacitinib. [PDF]

Case Rep Dermatol Med
Noble OR, Cohen DJ, Cooper L.
europepmc   +1 more source

Could the IL‐17 cytokine family be a promising target for the treatment of palmoplantar pustulosis?

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 728-729, May 2026.
Ulrich Mrowietz, Sascha Gerdes
wiley   +1 more source

Successful Treatment of Pityriasis Rubra Pilaris with Upadacitinib: Report of Two Cases. [PDF]

Acta Derm Venereol
Du Y, Liu X, Zhang L, Zhong J, He R.
europepmc   +1 more source

Translating 6‐year trial safety data of upadacitinib in atopic dermatitis into clinical practice

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 722-723, May 2026.
Lian F. van der Gang, Nicolaas P. A. Zuithoff, Marjolein S. de Bruin‐Weller   +2 more
wiley   +1 more source

Upadacitinib for Treatment-Refractory Esophageal Lichen Planus: A Retrospective Case Series. [PDF]

Gastro Hep Adv
Fikri L, Sia T, Bacchus L, Kumar A, Herath R, Leung J.   +5 more
europepmc   +1 more source

Modern Strategies in the Pharmacotherapy of Inflammatory Bowel Diseases – A Literature Review [PDF]

Introduction and Aim:Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are chronic, immune-mediated disorders of the gastrointestinal tract.
Boral, Aleksandra, Brzoza, Joanna, Czarnecki , Bartłomiej, Górski, Michał, Koczur, Julia, Kryś, Dominika, Kurkiewicz, Wojciech, Pniok, Wiktoria, Werenkowicz, Wiktor   +8 more
core   +1 more source